Vivaldi Biosciences names vice president of vaccine development
In this newly created position, Dr Wainwright has responsibility for the development of Vivaldi’s live attenuated vaccine candidates for seasonal and pandemic influenza, from preclinical evaluation through Phase
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.